SCHEMBL8740775

SCHEMBL8740775

O=C(c1ccccc1)C(Br)Br.O=C(c1ccccc1)C(Br)Br

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 7/20 0.60
TDP1 Q9NUW8 3/20 0.56
L3MBTL1 Q9Y468 2/20 0.56
CES1 P23141 5/20 0.54
CES2 O00748 4/20 0.54
LMNA P02545 1/20 0.54
TSHR P16473 2/20 0.50
DAO P14920 1/20 0.50
NAPRT Q6XQN6 1/20 0.50
MDM2 Q00987 1/20 0.50
ALDH1A1 P00352 1/20 0.50
PTPN1 P18031 1/20 0.46
CYP3A4 P08684 2/20 0.46
MAPT P10636 2/20 0.46
POLB P06746 1/20 0.46
PARP1 P09874 1/20 0.46
CYP2C19 P33261 1/20 0.46
RECQL P46063 1/20 0.46
BLM P54132 1/20 0.46
PMP22 Q01453 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL379271 1.00 GSK3B (0.60) GSK3BTDP1L3MBTL1CES1CES2
SCHEMBL3362417 0.86 GSK3B (0.57) GSK3BL3MBTL1LMNAALDH1A1PTPN1
SCHEMBL9644843 0.86 GSK3B (0.76) GSK3BTDP1L3MBTL1CES1CES2
SCHEMBL3703925 0.84 TDP1 (0.56) GSK3BTDP1L3MBTL1CES1CES2
SCHEMBL330776 0.84 TDP1 (0.56) GSK3BTDP1L3MBTL1CES1CES2
SCHEMBL9157738 0.84 TDP1 (0.56) GSK3BTDP1L3MBTL1CES1CES2
SCHEMBL2962521 0.82 GSK3B (0.64) GSK3BCES1CES2TSHRDAO
SCHEMBL2276402 0.82 CES1 (0.58) GSK3BTDP1L3MBTL1CES1CES2
SCHEMBL8488415 0.81 PARP10 (0.58) GSK3BPGRSMN1; SMN2
SCHEMBL3361986 0.81 KMO (0.60) GSK3BTDP1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0764017-A4 METHODS AND COMPOSITIONS FOR DISRUPTING THE EPITHELIAL BARRIER FUNCTION CELLEGY PHARMA INC (US) 1997-08-06 EP disclosed
EP-0764017-A1 METHODS AND COMPOSITIONS FOR DISRUPTING THE EPITHELIAL BARRIER FUNCTION CELLEGY PHARMACEUTICALS, INC. (US) 1997-03-26 EP disclosed
WO-1994021230-A1 METHOD AND COMPOSITIONS FOR DISRUPTING THE EPITHELIAL BARRIER FUNCTION CELLEGY PHARMACEUTICALS, INC. (US) 1994-09-29 WO disclosed